Partners
The ImmunoSABR project is consortium of 15 partners which has been created from leading Institutes within the EU . Working together their aim is to open up a new paradigm in treating metastatic cancer by obtaining clinical proof of concept for a novel bi-modal curative treatment strategy.
University College London
University College London Cancer Institute and the University College Hospital form a leading UK Comprehensive Cancer Centre, combining basic cancer [...]
Universitair Ziekenhuis Gent
UZ Gent is one of the largest and most specialized hospitals in Flanders, delivering a full range of highly specialized, [...]
Universitaets Klinikum Tuebingen
We are an academic tertiary care center treating 2500 new cancer patients per year (>45000 fractions). Our clinical and scientific [...]
UCSC
The Università Cattolica del Sacro Cuore is the most comprehensive and complete legally recognized university in Italy: it includes five [...]
The Cliniques Universitaires Saint-Luc
The Cliniques Universitaires Saint-Luc (CUSL - UCL) is one of the main academic hospitals of Brussels, and is currently treating [...]
Technische Universität Dresden
OncoRay is an interdisciplinary research center established in 2005 and financed by the Technische Universität Dresden, the University Hospital Dresden [...]
Radboudumc
Radboud university medical center is a leading academic center for patient care, education and research, with the mission ‘to have [...]
Philogen S.p.A
Philogen (http://www.philogen.com/) was founded in 1996 with the mission to develop new bio- pharmaceuticals for the treatment of angiogenesis-related disorders, [...]
NKI-AVL
The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL) is an integrated comprehensive cancer centre, combining a hospital and [...]
Maastricht UMC +
The University of Maastricht (UM) and the University Medical Center Maastricht (azM) work together under the umbrella organisation Maastricht UMC+, [...]
KU LEUVEN
The Leuven Lung Cancer Group (LLCG) is a world- wide recognised high-quality clinical and experimental hub in which innovative diagnosis [...]
Institut régional du Cancer Montpellier
https://www.icm.unicancer.fr/fr
Heidelberg University Hospital
https://www.klinikum.uni-heidelberg.de/
Health Innovation Ventures B.V.
Health Innovation Ventures B.V. aims to revolutionise healthcare through several approaches. Specifically, two departments of Health Innovation V entures will [...]
GasthuisZusters Zorg en Wonen Antwerpen
https://gzazorgenwonen.be/
Erasmus MC
https://www.erasmusmc.nl/
STAY INFORMED ?
If you want to stay informed about ImmunoSABR project, please subscribe to our newsletter.
CONTACT
The D-Lab / Precision Medicine
P.O. Box 616,
6200 MD Maastricht, The Netherlands
FUNDING
This project has received funding from the European Union’s. Horizon 2020 research and innovation programme under grant agreement No 733008